Alzheimer s & Dementia · 2021 · 40 citations · 41 references
MedicineGeriatric MedicineNeurologyCognitive NeurologyGeriatric PsychiatryNeuropsychiatryAlzheimer DiseaseAnxiety DisordersCognitive ImpairmentDementia BiomarkersDementia EpidemiologyDementia Risk FactorsAdditive Interaction ModelingAlzheimer Disease RiskAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloid PlaquesAnxiety-cognition InteractionNeurological Comorbidity
INTRODUCTION: We investigated the longitudinal relationship between cortical amyloid deposition, anxiety, and depression and the risk of incident mild cognitive impairment (MCI). METHODS: We followed 1440 community-dwelling, cognitively unimpaired individuals aged ≥ 50 years for a median of 5.5 years. Clinical anxiety and depression were assessed using Beck Anxiety and Depression Inventories (BAI, BDI-II). Cortical amyloid beta (Aβ) was measured by Pittsburgh compound B positron emission tomography (PiB-PET) and elevated deposition (PiB+) was defined as standardized uptake value ratio ≥ 1.48. We calculated Cox proportional hazards models with age as the time scale, adjusted for sex, education, and medical comorbidity. RESULTS: Cortical Aβ deposition (PiB+) independent of anxiety (BAI ≥ 10) or depression (BDI-II ≥ 13) increased the risk of MCI. There was a significant additive interaction between PiB+ and anxiety (joint effect hazard ratio 6.77; 95% confidence interval 3.58-12.79; P = .031) that is, being PiB+ and having anxiety further amplified the risk of MCI. DISCUSSION: Anxiety modified the association between PiB+ and incident MCI.
41
An inventory for measuring clinical anxiety: Psychometric properties.
Aaron T. Beck, Norman Epstein, Gary Brown et al. · Journal of Consulting and Clinical Psychology · 1988 · 11.7K citations
The Clinical Dementia Rating (CDR)
John C. Morris · Neurology · 1993 · 10K citations
Medicine, Neurology, Psychiatry +12